What does CUSIP 45845P908 represent in this 13F holders report?

CUSIP 45845P908 is the security identifier for 45845P908 - INTERCEPT PHARMACEUTICALS IN - CALL used to aggregate holder disclosures.

How many institutions held 45845P908 - INTERCEPT PHARMACEUTICALS IN - CALL in Q2 2023?

No institutional holders were reported for 45845P908 - INTERCEPT PHARMACEUTICALS IN - CALL in Q2 2023; review adjacent reporting periods for trend context.

INTERCEPT PHARMACEUTICALS IN - CALL

CUSIP: 45845P908

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / CALL
Price per share: $11.06
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 45845P908?
CUSIP 45845P908 identifies 45845P908 - INTERCEPT PHARMACEUTICALS IN - CALL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 45845P908:

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022

INTERCEPT PHARMACEUTICALS IN - CALL

Q2 2023 13F Holders as of 30 Jun 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of INTERCEPT PHARMACEUTICALS IN - CALL as of Q2 2023.